CSI Market
Sign In | Register

Global Cord Blood (CO) Annual Income Statement

Annual · GAAP · USD millions
Access CO quarterly income statements →
This income statement overview for Global Cord Blood spans from Mar 31 2018 to Mar 31 2022, showing how the company's revenues, expenses, and earnings have changed across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Mar 31 2022)
2022 		(Mar 31 2021) (Mar 31 2020) (Mar 31 2019) (Mar 31 2018)
Revenues
Sales Revenue, Services, Net0.00
Revenue From Contract With Customer Including Assessed Tax196.12
Total Revenue196.12
Costs & Expenses
Cost of Goods and Services Sold28.92
Gross Profit167.20
Selling, Administration, Marketing10.24
Depreciation & Amortization0.73
Research and Development Expense3.52
Other Operating Expense / -Income0.00
Total operating costs including COS71.16
Operating income / -loss96.05
Interest Expense0.00
Net Interest Expense / -Income0.00
Loss / -Gain on Investment0.18
Foreign Currency Transaction Gain (Loss), before Tax-0.10
Other loss / -income-2.89
Total costs & expenses97.08
Income & Taxes
Income / -loss before income taxes99.04
Income taxes expenses / -benefit18.16
Income after income taxes80.37
Income / -loss from continuing operations80.37
Non-controlling interests1.33
Net income / -loss80.37
Income / -loss to shareholder79.04
EBIT99.04
EBITD99.04
EBITDA99.04
Earnings Per Share
Basic EPS (excl. extra items)4.12
Basic Net EPS4.12
Basic shares outstanding (Mill. of Units)121.55
Diluted Net EPS4.12
Diluted average shares (Mill. of Units)121.55
Dividend per share0.00
4 historic quarters locked

Sign in to unlock the full Global Cord Blood income statement history.

Sign In Create Free Account

About CO Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.